|
Located in Princeton, NJ...
Novo Nordisk is a focused healthcare company and a world leader in diabetes care.
We believe action defines leadership.
The status quo is just not good enough. We are actively working to change the course of the diabetes pandemic, improve the daily lives of people with diabetes, and to expand the possibilities for people with hemophilia. Innovation and personal passion are the hallmarks of how we operate.
Our company’s history is full of firsts, and we will continue to tap that well of innovation to not only develop ever-more effective treatment options for the patients we serve but also innovation in education, and leadership, advocacy.
Personal passion about the well-being of people with chronic illness has always been at the heart of our company. Our roots reach far back to a man driven to find an innovative treatment for his wife, in 1923.
We carry that same passion and commitment beyond diabetes into our work for people with growth disorders and women requiring hormone therapy.
Since that start, the company’s care for the individual’s well-being blossomed into a deep sense of responsibility for all of society. An early adopter of the triple bottom line approach to business, Novo Nordisk remains a leading proponent of balancing its environmental impact, social contribution, and financial results.
In his Welcome Letter , the company’s U.S. President,Jerzy Gruhn, shares more about the company’s presence and activities, particularly here in the United States.
|